Research projects
Start of main content
The identification of new genes responsible for Hereditary Dystrophies of the Retina using Next-Generation Sequencing technology and the determination of associated pathogenic mechanisms
16th national competition for scientific and technical research
Rare diseases
Research Centre or Institution : Hospital Universitario Virgen del Rocío. Sevilla.
Abstract
Hereditary Dystrophies of the Retina (HDR) are extraordinarily complex and genetically heterogeneous pathologies. Despite the intense efforts made to map them over the past two decades, the mutations detectable in known genes only explain a relatively small percentage of cases. Therefore, many HDR genes have yet to be identified, as well as mutations in regions not usually analysed. During this year work has been undertaken towards objectives 1 and 2, as described in detail in the report accompanying the application. To date, the families to be included within the cohort have been clinically evaluated and selected. Priority has been given to the study of families affected by recessive autosomal retinitis pigmentosa (RPar) in which the underlying genetic cause has not been detected by the techniques used to date. Analysis of these families took place following version 1.0 of the Medical Genome Project protocol for the selective recruitment of exomes and subsequent massive sequencing using the SOLiD 5500xl platform. The reading from these sequencers were aligned against the hg19 human reference genome. Variants were identified using GATK (Genome Analysis Toolkit) software. Secondary analysis was undertaken by following two complementary approaches: VAAST (Variant Annotation, Analysis and Selection Tool) and a tool developed at the Prince Felipe Research Centre (CIPF, Valencia). 7 families have been analysed to date, with a total of 28 individuals. Subsequent biocomputation analysis has resulted in the identification of different candidate genes. Work is currently taking place to validate these genes and their possible involvement in RPar. To summarise, the search for new mutational events using new technologies will make it possible to advance in the study of the molecular bases of DHR, offering new expectations for their treatment.
-
Activities related
-
Projects related
-
News related
-
Publications related
-
27
Nov
2019
International Symposium Undiagnosed and rare diseases in children and adolescents: Translation to clinic and society Barcelona, Wednesday and Thursday, November 27 and 28, 2019 9:30 hours
-
30
Jan
2020
International Symposium Understanding and reprogramming developmental visual disorders: from anophthalmia to cortical impairments Madrid, Thursday and Friday, 30 and 31 January 2020, 9:30 hours
-
26
Sep
2022
Conference Terapia génica y celular avanzada… Más allá de la última frontera Madrid, Monday, 26 September 2022, 19:00 hours
- Phenotyping of animal models of rare diseases with visual disability 2020 Senior Researcher : Lluís Montoliu José Research Centre or Institution : Centro Nacional de Biotecnología (CNB). CSIC. Madrid
- The neuronal glycine transporter GlyT2 in herplexia: a glycinergic pathology of development 2020 Senior Researcher : Beatriz López Corcuera Research Centre or Institution : Centro de Biología Molecular Severo Ochoa. CSIC - UAM
- Serum markers in patients with congenital melanocytic nevi: clinicopathological and genetic correlation 2020 Senior Researcher : Pedro Redondo Bellón Research Centre or Institution : Clínica Universidad de Navarra. Pamplona
-
-
Eric D. Green: “La genómica debe integrarse en la medicina convencional”
Published on 03/12/2021
End of main content